RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Quercetin
Inhibition of entry
2D Structure
Loading structure...
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
InChI Key:
REFJWTPEDVJJIY-UHFFFAOYSA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
11
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT04468139
Hepacivirus C
HCV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:26621580
Rhinovirus A
HRV-A1B
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:22465313
Rhinovirus A
HRV-A39
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:22465313
Influenza A virus
FLUAV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:26712783
Human respirovirus 3
HPIV-3
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:2981979
Human alphaherpesvirus 1
HSV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:16350858
Human alphaherpesvirus 2
HSV-2
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:16350858
Enterovirus C
PV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:2981979
Human orthopneumovirus
RSV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:2981979
Severe acute respiratory syndrome-related coronavirus
SARS-CoV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:15452254